Ironwood Pharmaceuticals
Listing Websites about Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
(7 days ago) Oops! Something went wrong, please try again later.Add hoursAdd photosOops! Something went wrong, please try again later.WebsiteDirectionsContact usOops! Something went wrong, please try again later.Suggest an edit · Your business? Claim nowIronwood Pharmaceuticals – a leading gastrointestinal (GI) …https://ironwoodpharma.comWebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI …
Url: Visit Now
Category: Pharmaceutical, Health Detail Drugs
Ironwood Pharmaceuticals - Wikipedia
(4 days ago) WebIronwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc. Microbia was founded by postdocs from the lab of Gerald …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Ironwood Pharmaceuticals, Inc. (IRWD) - Yahoo!
(6 days ago) WebFind the latest Ironwood Pharmaceuticals, Inc. (IRWD) stock quote, history, news and other vital information to help you with your stock trading and investing.
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Equities Analysts Set Expectations for Ironwood Pharmaceuticals, …
(8 days ago) WebIronwood Pharmaceuticals has a 1 year low of $9.73 and a 1 year high of $12.95. The firm has a market cap of $1.76 billion, a price-to-earnings ratio of 12.09 and …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Capital One Financial Weighs in on Ironwood Pharmaceuticals, …
(2 days ago) WebIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Rating) - Analysts at Capital One Financial dropped their Q4 2022 EPS estimates for Ironwood …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Ironwood Pharmaceuticals Provides Update on FY 2022 Financial …
(7 days ago) WebIronwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance …
Url: Visit Now
Category: Pharmaceutical, Health Detail Drugs
Ironwood Pharmaceuticals LinkedIn
(7 days ago) WebIronwood Pharmaceuticals Pharmaceutical Manufacturing Boston, MA 27,081 followers Ironwood is on a mission to advance treatment of gastrointestinal diseases & redefine …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Ironwood Pharmaceuticals IRWD Stock Price, …
(8 days ago) WebIronwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. Leveraging Big Data multi-factor models, the Q-Factor Score is assigned to each stock ranging from “Top Buy” to
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Contact Us : Novadoz - Novadoz Pharma
(6 days ago) WebSUITE A. PISCATAWAY, NEW JERSEY 08854-3714. LOCAL: (908) 360-1500. TOLL FREE: (855) NOVADOZ (855-668-2369) CUSTOMER SERVICE: (848) 200-1904. Thank …
Url: Visit Now
Category: Health Detail Drugs
Company Profile : Novadoz
(1 days ago) WebNovadoz Pharmaceuticals is the U.S affiliated sales & marketing organization for MSN. MSN customer base exceeds two hundred fifty (250) with a global presence in sixty-five …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
› Medical office professional certificate
› Southern california health insurance plans
› Hospitals near jacksonville florida
› Medical equipment bank tacoma
Recently Searched› Benefits of care coordination
› Employee mental health day off
› Ncaa best practices mental health
› U of illinois medical school
› 1963 community mental health act
› Printable mental health crisis plan
› Online certifications for mental health
› What is intensive outpatient care
FAQ about Ironwood Pharmaceuticals
Is Ironwood Pharmaceuticals a publicly traded company?
Boston, Massachusetts. Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc..
What does Ironwood do?
At Ironwood, we're focused on delivering differentiated medicines to patients and generating outstanding returns for shareholders. If we do this efficiently and effectively, we hope to inspire continued support so that we can seek to develop and deliver more medicines for patients living with GI diseases.
Will Ironwood Pharmaceuticals host fourth quarter and full year 2021 call?
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Investor Update Call
What happened to the anxiolytic that Ironwood abandoned?
BNC210 is an anxiolytic that Ironwood licensed and performed R&D on and then abandoned. In April 2018, the shares of Ironwood Pharmaceuticals closed up more than 10 percent on the news of biotech activist investor, Alex Denner joining its board.